LipoMed developed a new assay, one that is twice as powerful as the standard cholesterol panel in predicting the risk for Coronary Heart Disease. They were having trouble meeting sales projections.
Forma helped rename LipoScience, and developed a new corporate identity and brand position. Forma designed print collateral, developed diagrams to explain the value and physiology of the assay, and designed trade-show booths and other materials. Forma developed new direct-to-clinician sales-support materials. Several phases of market research were conducted prior to and after the new material had been completed.
Our marketing efforts resulted in a 60% increase in the perceived value of the test, and our work was a finalist in the MM&M awards.